Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 16:10 ET | Source: LanzaTech Inc.

LanzaTech Achieves Guaranteed Performance at Japan MSW-to-Ethanol Plant

Achieved ethanol yields exceeding guaranteed performance for over 14 consecutive days at steady stateSuccessfully operated on complex syngas streams with CO + H₂ contents as low as 40%Demonstrated...
January 07, 2026 16:05 ET | Source: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026 Planned milestones include pivotal dose selection, EOP2 regulatory interaction in mid-2026, updated and...
January 07, 2026 16:05 ET | Source: Terrestrial Energy Inc.

Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference

CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its...
January 07, 2026 16:05 ET | Source: Twelve Seas Investment Company III

Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026

New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company”) announced today that, commencing January 9, 2026, holders of the units sold in the...
January 07, 2026 16:05 ET | Source: Bitfarms Ltd.

Bitfarms to Present at Needham Growth Conference in NYC

TORONTO, Ontario and NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a North American energy and digital infrastructure company, will participate in Needham’s 28th...
January 07, 2026 16:05 ET | Source: Krystal Biotech, Inc.

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

PITTSBURGH, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that it will host an investor conference call and webcast tomorrow, Thursday,...
January 07, 2026 16:05 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
January 07, 2026 16:05 ET | Source: LifeVantage Corporation

LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation

SALT LAKE CITY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the...
January 07, 2026 16:05 ET | Source: Kura Sushi USA

Kura Sushi USA Announces Fiscal First Quarter 2026 Financial Results

IRVINE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial...
January 07, 2026 16:05 ET | Source: Abivax

Abivax Provides 2026 Corporate Outlook

Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market...